Your session is about to expire
← Back to Search
Study Summary
This trial tests how well a new drug works in healthy adults and how long it stays in their bodies.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Is the study open to geriatric patients?
"This trial is seeking volunteers aged between 18 and 65."
What are the risk factors associated with Part 1: Sequence A?
"Due to the limited empirical evidence regarding safety and effectiveness, our team at Power gave Part 1: Sequence A a score of one on its risk scale."
Who is eligible to enroll in this research project?
"Prospective participants of the trial must be within 18 and 65 years old, with no pre-existing health issues. A cap of 24 patients is in place for this experiment."
Are participants currently being enrolled in this research endeavor?
"Affirmative. Clinicaltrials.gov data shows that the search for participants is currently in progress; this medical trial was first posted on April 24th 2023 and has since been updated most recently on April 20th 2023. The clinical study requires 24 patients to be recruited from one site."
What is the aggregate enrollment of this clinical trial?
"Indeed, clinicaltrials.gov reveals that this medical trial is presently accepting patients. The study was first announced on April 24th 2023 and recently edited on the twentieth of April in the same year. A total of 24 participants are being recruited from only one site."
Share this study with friends
Copy Link
Messenger